---All---
  • ---All---
  • Accession
  • Catalog #

NF-?B p65 AntibodyMouse Monoclonal Antibody to NF-?B p65

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AO1321a 0.1ml 400 ul 7-10 days $ 325.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

NF-?B p65 Antibody - Product info

ApplicationWB
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionQ04206
Other AccessionNP_068810.3
ReactivityHuman, Mouse
IsotypeMouse IgG1
Clone Names6H7
Calculated MW60219 Da

NF-?B p65 Antibody - Additional info

Gene ID 5970
Other Names
NFkappaB p65; p65; NFKB3; RELA
Target/Specificity
Purified recombinant fragment of human NF-?B p65 expressed in E. Coli.
Dilution
WB~~1:500 - 2000.
Format
Purified recombinant fragment of human NF-?B p65 expressed in E. Coli.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
NF-?B p65 Antibody is for research use only and not for use in diagnostic or therapeutic procedures.

NF-?B p65 Antibody - Protein Information

Name RELA
Synonyms NFKB3
Function
NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and p65-c-Rel complexes are transcriptional activators. The NF-kappa-B p65-p65 complex appears to be involved in invasin-mediated activation of IL-8 expression. The inhibitory effect of I-kappa-B upon NF-kappa-B the cytoplasm is exerted primarily through the interaction with p65. p65 shows a weak DNA-binding site which could contribute directly to DNA binding in the NF-kappa-B complex. Associates with chromatin at the NF-kappa-B promoter region via association with DDX1
Cellular Location
Nucleus. Cytoplasm. Note=Colocalized with DDX1 in the nucleus upon TNF-alpha induction (By similarity) Nuclear, but also found in the cytoplasm in an inactive form complexed to an inhibitor (I-kappa-B). Colocalizes with GFI1 in the nucleus after LPS stimulation

NF-?B p65 Antibody - Related products

AP3176a: Phospho-NFKBp65-S536 Antibody

AP3178a: Phospho-NFKB-S536 Antibody

AP3717a: Phospho-NF kappa B-S276 Antibody

AP3749a: Phospho-NF kappa B-S536 Antibody

AP6826a: RELA Antibody (N-term)

AP6826c: RELA Antibody (Center)

AP9455a: NF kappa B-S276

RI14507: RELA predesign siRNA

LY10116a: RELA Over-expression Lysate

BP3176a: Phospho-NFKBp65-S536 Antibody Blocking Peptide

BP3178a: Phospho-NFKB-pS536 Antibody Blocking Peptide

BP3717a: Phospho-NF kappa B-S276 Antibody Blocking Peptide

BP6826a: RELA Antibody (N-term) Blocking Peptide

BP6826c: RELA Antibody (Center) Blocking Peptide

BP9125c: NF kappa B-S276 Antibody Blocking Peptide

BP9455a: NF kappa B-S276 Blocking Peptide

AT3616a: RELA Antibody (monoclonal) (M01)

AO1321a: NF-?B p65 Antibody

AJ1537a: NF-kappaB Antibody (p65 subunit)

AJ1539a: NF-kappa-B p65 Antibody

AJ1539b: NF-kappa-B p65 Antibody Phospho (pS536)

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

Transcription factors of the nuclear factor ? B (NF-?B)/Rel family is a ubiquitously expressed transcription factor that regulates many cytokine and Ig genes. It is involved in immune, inflammatory, viral, and acute phase responses. There are five family members in mammals: RelA (p65), c-Rel, RelB, NF-?B1 (p105/p50) and NF-?B2 (p100/p52). The most studied NF-?B complex consists of the p50 and p65 subunits, both containing a 300 amino acid region with homology to the Rel proto-oncogene product. The p50 subunit binds DNA, whereas the p65 subunit is responsible for the interaction of NF-?B with its inhibitor, I?B. In most cell types, the p50/p65 heterodimer is located within the cytoplasm complexed to I?B. This complex prevents nuclear translocation and activity of NF-?B. In response to stimuli such as cytokines, LPS, and viral infections, I?B is phosphorylated at critical residues. This phosphorylation induces dissociation of the I?B/NF-?B complex, allowing the free heterodimeric NF-?B to form a heterotetramer that translocates to the nucleus. In the nucleus, it binds to the ?B site within promoters and enhancers and functions as a transcriptional activator.

REFERENCES

1. Nature. 1997 Aug 7;388(6642):548-54.
2. Cell. 1998 Dec 11;95(6):749-58.
3. J Biol Chem. 2000 Jun 16;275(24):18180-7.